|
Untitled Document
|
 |
 |
| |
|
 |
|
| ¤ýSeries
50XMO |
|
| |
For
obstetric clinicians who require maternal monitoring for
high-risk patients, or patients receiving anesthesia during
labor and delivery, the Series 50 XMO provides a fully
integrated fetal and maternal monitoring solution, reducing
the perception of technology and monitoring equipment
at the bedside.
|
| |
The integrated Fetal Pulse Oximetry provides
crucial, continuous information on the fetus' oxygen status.
Measuring fetal oxygen saturation may help reduce the
uncertainty associated with non-reassuring fetal heart
rates by providing an additional paramenter which has
not been available in the past.
|
The
Series 50 XMO can be configured to meet your needs now
and is upgradable for future needs as it keeps pace with
changes in technology. The Series 50 XMO offers added
functionality to the Series 50 XM with built-in fetal
pulse oximetry based on proven OxiFirstTM, technology
from Nellcor, a Tyco Healthcare business unit.
|
| This product
is currently not available in the USA and Japan. |
|
| ¤ýBenefits |
| * |
Fetal oxygen saturation
measurements, based on proven OxiFirstTM fetal pulse oximetry
technology from NellCor, a Tyco Healthcare business unit |
| |
| * |
The enhanced Cross Chanel
Verification (CCV+), gives additional certainty for measuring
fetal oxygen saturation, reducing the risk of accidentally monitoring
the maternal SpO2 |
| |
| * |
Comprehensive recording
of maternal parameters on fetal trace, which includes maternal
HR, NIBP and SpO2 and continuous maternal electrocardiogram |
| |
| * |
Unparalleled investment protection
- past, present and future. The Series 50 XMO is the platform
monitor where new innovations will be added |
| |
|
|
| |
|
|
 |
|
